John E. Kerrigan

2.6k citations

53 papers · 2.0k indexed · h-index 24

Toxicology top 2%
Molecular Biology top 10%
- RNA Interference and Gene Delivery 6
- Cancer therapeutics and mechanisms 5
- Biochemical and Molecular Research 4
- Protein Kinase Regulation and GTPase Signaling 4
- DNA and Nucleic Acid Chemistry 4
Cancer Research top 10%
- Synthesis and Biological Activity 4
- Cancer, Hypoxia, and Metabolism 4
Oncology top 10%
Cardiology and Cardiovascular Medicine top 5%
Organic Chemistry
- Synthesis and Biological Evaluation 5

Co-authors: Daniel S. Pilch Leroy F. Liu Yi Lisa Lyu Yuan‐Chin Tsai Chao‐Po Lin Anna M. Azarova Yi Ban Malvika Kaul
Cited by: Toxicology Molecular Biology Cancer Research
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Biological Chemistry (3 papers)Journal of Medicinal Chemistry (3 papers)
Partner nations: United States Netherlands United Kingdom

In The Last Decade

John E. Kerrigan

53 papers receiving 2.0k citations

Peers

Countries citing papers authored by John E. Kerrigan

Since Specialization

Citations

This map shows the geographic impact of John E. Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Kerrigan more than expected).

Fields of papers citing papers by John E. Kerrigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Kerrigan. The network helps show where John E. Kerrigan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John E. Kerrigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Kerrigan Line = papers co-authored together John E. Kerrigan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer Clinical Cancer Research ·Nitu Bansal,Monica Bartucci,Shamila Yusuff,Stephani A. Davis,Gwangsick Jung,María Luisa Torres Machi,Michele Patrizii,Daniel M. Jones,Liangxian Cao,Nadiya Sydorenko,Young‐Choon Moon,H. Zhong,Daniel Medina,John E. Kerrigan,Mark N. Stein,Isaac Yi Kim,Thomas W. Davis,Robert S. DiPaola,Joseph Bertino,Hatem E. Sabaawy	2016	49
2	Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas BMC Cancer ·V Strobl,Vessela N. Kristensen,Michael Seiler,Surendra Kumar,Grethe I.G. Alnæs,Ming Yao,John E. Kerrigan,Bjørn Naume,Ravi Sachidanandam,Gyan Bhanot,Anne‐Lise Børresen‐Dale,Shridar Ganesan	2015	24
3	RNase H: Specificity, Mechanisms of Action, and Antiviral Target Methods in molecular biology ·Karin Moelling,Felix Broecker,John E. Kerrigan	2013	9
4	Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction Bioorganic & Medicinal Chemistry Letters ·Longqin Hu,Sadagopan Magesh,Lin Chen,Lili Wang,Timothy A. Lewis,Yu Chen,Carol Khodier,Daigo Inoyama,Lesa J. Beamer,Thomas J. Emge,Jian Shen,John E. Kerrigan,Ah‐Ng Tony Kong,Sivaraman Dandapani,Michelle Palmer,Stuart L. Schreiber,Benito Muñoz	2013	159
5	Enterococcal and streptococcal resistance to PC190723 and related compounds: Molecular insights from a FtsZ mutational analysis Biochimie ·Malvika Kaul,Juanjuan zhang,Ajit K. Parhi,Edmond J. LaVoie,Steve Tuske,Eddy Arnold,John E. Kerrigan,Daniel S. Pilch	2013	20
6	Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs Molecular Pharmacology ·R. De Waele,Philip M. Tedeschi,寛松沢,Debabrata Banerjee,Kathleen W. Scotto,John E. Kerrigan,Chopendra G. Wasnik,Nadine Johnson-Farley,Joseph R. Bertino,Emine Ercikan Abali	2012	27
7	Role of Computational Methods in Pharmaceutical Sciences Methods in molecular biology ·Sandhya Kortagere,Markus A. Lill,John E. Kerrigan	2012	9
8	Dietary Isothiocyanate-induced Apoptosis via Thiol Modification of DNA Topoisomerase IIα Journal of Biological Chemistry ·Thomas J. Leck,Nai Zhou,Yi Lisa Lyu,Yuan-Chin Tsai,Chang-Hsien Lu,John E. Kerrigan,(unknown),Ziqiang Guan,Tao‐shih Hsieh,Leroy F. Liu	2011	45
9	Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes Breast Cancer Research and Treatment ·邹霆,Alexei Vázquez,Diptee Kulkarni,John E. Kerrigan,Gurinder S. Atwal,Prinz Elad,Deborah Toppmeyer,Arnold J. Levine,Kim M. Hirshfield	2010	25
10	Modeling and biochemical analysis of the activity of antibiofilm agent Dispersin B Acta Biologica Hungarica ·John E. Kerrigan,C. Ragunath,Lili Kandra,Gyöngyi Gyémánt,András Lipták,R.A. Vozgrin,Jack H. Kaplan,N. Ramasubbu	2008	20
11	Synthesis and G-quadruplex stabilizing properties of a series of oxazole-containing macrocycles Bioorganic & Medicinal Chemistry Letters ·IkeS. Okwuosa,Daniel S. Pilch,John E. Kerrigan,Edmond J. LaVoie,Joseph E. Rice	2006	64
12	Follitropin receptors contain cryptic ligand binding sites Molecular and Cellular Endocrinology ·S. Namba,Michael P. Bernard,Donghui Cao,Rebecca V. Myers,John E. Kerrigan,William R. Moyle	2006	11
13	Coupling of Drug Protonation to the Specific Binding of Aminoglycosides to the A Site of 16S rRNA: Elucidation of the Number of Drug Amino Groups Involved and their Identities Journal of Molecular Biology ·Malvika Kaul,Christopher M. Barbieri,John E. Kerrigan,Daniel S. Pilch	2003	103
14	5H-8,9-Dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-Targeting agents: influence of structure on the ternary cleavable complex formation Bioorganic & Medicinal Chemistry Letters ·John E. Kerrigan,Daniel S. Pilch,Alexander L. Ruchelman,Nai Zhou,Angela Liu,Leroy F. Liu,Edmond J. LaVoie	2003	11
15	6-Acylamino-2-[(alkylsulfonyl)oxy]-1H-isoindole-1,3-dione mechanism-based inhibitors of human leukocyte elastase Bioorganic & Medicinal Chemistry Letters ·John E. Kerrigan,Anpel Rizaldy,允滝澤,M.J. Reike,Lisa J. Christopher	2000	12
16	A Serine Proteinase Inactivator Inhibits Chondrocyte-Mediated Cartilage Proteoglycan Breakdown Occurring in Response to Proinflammatory Cytokines Archives of Biochemistry and Biophysics ·Wu Dacheng Du Peng Kang Jian,R.A.D. Bunning,Ruth E. Feltell,Chih Min Kam,John E. Kerrigan,James C. Powers,David J. Buttle	1998	14
17	4-Chloro-7-(iodoacetyl)amino-3-methoxyisocoumarin Acta Crystallographica Section C Crystal Structure Communications ·John E. Kerrigan,James C. Powers,Don VanDerveer	1996	3
18	Mechanism-Based Isocoumarin Inhibitors for Blood Coagulation Serine Proteases. Effect of the 7-Substituent in 7-Amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on Inhibitory and Anticoagulant Potency Journal of Medicinal Chemistry ·Chih-Min Kam,John E. Kerrigan,R. Richard Plaskon,Zhuo Liu,Pete Lollar,F. L. Suddath,James C. Powers	1994	48
19	Inhibition of Porcine Pancreatic Elastase by 7-Substituted 4-Chloro-3-Ethoxyisocoumarins: Structural Characteristics of Modeled Noncovalent Complexes Relate to the Measured Inhibition Kinetics Archives of Biochemistry and Biophysics ·R. Richard Plaskon,Chih Min Kam,John E. Kerrigan,Edward M. Burgess,James C. Powers,F. L. Suddath	1993	3
20	Substrate and inhibitor studies on proteinase 3 FEBS Letters ·Chih-Min Kam,John E. Kerrigan,Koert M. Dolman,Roel Goldschmeding,A. E. G. Kr. von dem Borne,James C. Powers	1992	51

About John E. Kerrigan

John E. Kerrigan is a scholar working on Molecular Medicine, Cancer Research, Toxicology, Molecular Biology and Organic Chemistry, having authored 53 papers that have together received 2.0k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (5 papers), Biochemical and Molecular Research (4 papers), Synthesis and Biological Activity (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), DNA and Nucleic Acid Chemistry (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Toxicology (84 citations), Molecular Biology (1.2k citations), Cancer Research (256 citations), Oncology (416 citations) and Cardiology and Cardiovascular Medicine (347 citations). John E. Kerrigan has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Daniel S. Pilch, Leroy F. Liu, Yi Lisa Lyu, Yuan‐Chin Tsai, Chao‐Po Lin, Anna M. Azarova, Yi Ban, Malvika Kaul, Joseph R. Bertino and Christopher M. Barbieri. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Journal of Medicinal Chemistry, Clinical Cancer Research and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact